Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1692234 Seattle, WA
Back to AGIO Full portfolio

Position in AGIO

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,481,023
+$1,137,637 QoQ
Shares Held
66,856
+68.4% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 85% Shared 0% None 15%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. AGIO ranks #77 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in AGIO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,481,023 66,856
2026-03-31 $1,343,386 39,710
2025-12-31 $671,758 24,679
2025-09-30 $275,198 6,856
2025-06-30 $309,051 9,292
2025-03-31 $250,748 8,558
2024-12-31 $91,415 2,782
2024-09-30 $123,470 2,779
2024-06-30 $250,872 5,818
2024-03-31 $19,619 671
2023-12-31 $13,450 604
2023-09-30 $55,512 2,243
2023-06-30 $83,685 2,955
2023-03-31 $1,144,823 49,840
2022-12-31 $1,060,636 37,772
2022-09-30 $943,023 33,346
2022-06-30 $864,384 38,989
2022-03-31 $1,270,272 43,637
2021-12-31 $1,926,181 58,600
2021-09-30 $4,951,617 107,294
2021-06-30 $7,706,967 139,847
2021-03-31 $6,003,613 116,259
2020-12-31 $6,496,768 149,937
2020-09-30 $3,346,070 95,602
2020-06-30 $2,185,512 40,866
2020-03-31 $17,207 485